Weerawat Manosuthi
Result (s) : 8
Vol. 35 No. 3 Sep. -Dec. 2018
Epidemiology and Clinical Characteristics of Patients under Investigation for Middle East Respiratory Syndrome Coronavirus Infection in Thailand
M.D.Patama Suttha, M.D.Chariya Sangsajja, M.D.Surasak Wiboonchutikul, M.D.Napat Chitwarakorn, Pannee Ritsumrage, Uajai Jeamsak, Ph.D.Sumonmal Uttayamakul, M.D.Weerawat Manosuthi
Vol. 34 No. 1 Jan-April 2017
Effectiveness and Safety of Generic Meropenem for the Treatment of Hospital-acquired Infections
M.D.Weerawat Manosuthi, M.D.Surasak Wiboonchutikul, M.D.Napat Chitwarakorn, Wiroj Mankatitham, nayot panitantum, M.D.suparat khemnark, M.D.Patama Sutha
Vol. 21 No. 2 May.-Aug. 2004
Genotypic Resistance in HIV-infected Patients Failing a d4T/3TC/NVP Regimen
M.D.Somnuek Sungkanuparph, M.D., M.H.S.Sasisopin Kiertiburanakul, M.D.Weerawat Manosuthi, Ph.D.Wasun Chantratita
Vol. 24 No. 2 May.-Aug. 2007
Role of Efavirenz in HIV-infected Patients with Preceding Nevirapine-related Skin Rash
M.D.Weerawat Manosuthi, M.D.Somnuek Sungkanuparph
Vol. 28 No. 3 Sep. - Dec. 2011
Isoniazid Preventive Therapy and Incidence of Pulmonary Tuberculosis among HIV-infected Patients on Antiretroviral Therapy: A 4-year Study
M.D., M.Sc.Thana Khawcharoenporn, M.D.Anucha Apisarnthanarak, M.D.Weerawat Manosuthi, M.D.Somnuek Sungkanuparph, Linda M. Mundy
Vol. 28 No. 3 Sep. - Dec. 2011
Incidence of Opportunistic Infections and Threeyear Survival Rate after Introducing Anti-retroviral Treatment in Advanced HIV-1 and Tuberculosis Co-infected Patients
Preawphan Punyaratabandhu, M.D.Weerawat Manosuthi
Vol. 28 No. 3 Sep. - Dec. 2011
Time to Initiation of Antiretroviral Therapy between 4 Weeks and 12 Weeks of Tuberculosis Treatment in HIV-1 Infected Patients: Results from the TIME Study
M.D.Weerawat Manosuthi, Aroon Lueangniyomkul, Wiroj Mankatitham, M.DSupeda Thongyen, M.D.Sirirat Likanonsakul, Pawita Suwanvattana, Unchana Thawornwan, Busakorn Suntisuklappon, Samruay Nilkamhang, M.D.Somnuek Sungkanuparph
Vol. 29 No. 3 Sep. - Dec. 2012
Prevalence and risk factors for clinically significant drug interactions among patient treated with antiretroviral agents
Apichot So-Ngern, M.D.Weerawat Manosuthi